Q&A with Mark S. Miller, Co-founder, Chairman and CEO of BirchBioMed Inc. Developing an Antifibrotic Therapeutic for the Prevention of Scaring and Breaking Down Existing Scars and an Autoimmune Platform for Reversing Type l Diabetes